We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+15.78%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$530M
Cap. Flow
% of AUM
3.93%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
339
New
59
Increased
111
Reduced
94
Closed
41
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$157M |
| 2 |
Johnson & Johnson
JNJ
|
+$155M |
| 3 |
Chegg
CHGG
|
+$87.6M |
| 4 |
Medtronic
MDT
|
+$72.1M |
| 5 |
Humana
HUM
|
+$69.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$133M |
| 2 |
Ciena
CIEN
|
+$99.1M |
| 3 |
Advanced Micro Devices
AMD
|
+$79.2M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$73.2M |
| 5 |
AYX
Alteryx Inc
AYX
|
+$70M |
Sector Composition
| 1 | Technology | 35.47% |
| 2 | Healthcare | 19.83% |
| 3 | Financials | 14.52% |
| 4 | Communication Services | 13.91% |
| 5 | Consumer Discretionary | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Baxter International
BAX
$11.7B
| $14.8M | 0.11% |
183,938
-641,166
| -78% | -$53.9M |
|
152
Thermo Fisher Scientific
TMO
$198B
| $14.7M | 0.11% |
33,188
-50,755
| -60% | -$21M |
|
153
Rockwell Automation
ROK
$51.4B
| $14.6M | 0.11% |
66,151
+3,873
| +6% | +$865K |
|
154
Alnylam Pharmaceuticals
ALNY
$35.7B
| $14.6M | 0.11% |
100,000
+25,000
| +33% | +$3.55M |
|
155
LivePerson
LPSN
$20.7M
| $14.5M | 0.11% |
18,562
+2,814
| +18% | +$2.11M |
|
156
JPMorgan Chase
JPM
$907B
| $14.3M | 0.11% |
148,168
-2,573
| -2% | -$253K |
|
157
LiveRamp
RAMP
$2.3B
| $13.4M | 0.1% |
+259,539
| New | +$13M |
|
158
Cognex
CGNX
$10.7B
| $13.2M | 0.1% |
203,015
-621,387
| -75% | -$40.2M |
|
159
Booking.com
BKNG
$141B
| $13.2M | 0.1% |
192,625
-104,175
| -35% | -$7.32M |
|
160
DexCom
DXCM
$29.6B
| $13.1M | 0.1% |
126,660
-69,412
| -35% | -$7.25M |
|
161
Cencora
COR
$59.9B
| $13.1M | 0.1% |
134,663
-375,337
| -74% | -$37.3M |
|
162
Wolfspeed
WOLF
$1.55B
| $12.3M | 0.09% |
193,004
-71,771
| -27% | -$4.65M |
|
163
Ascendis Pharma A/S
ASND
$17.1B
| $11.8M | 0.09% |
76,643
+25,000
| +48% | +$3.59M |
|
|
MODV
164
DELISTED
ModivCare
MODV
| $11.1M | 0.08% |
+119,276
| New | +$10.3M |
|
165
Neurocrine Biosciences
NBIX
$17.2B
| $10.9M | 0.08% |
112,878
+23,000
| +26% | +$2.66M |
|
|
APTO
166
DELISTED
Aptose Biosciences, Inc.
APTO
| $10.8M | 0.08% |
4,012
+1,172
| +41% | +$2.92M |
|
167
Acadia Pharmaceuticals
ACAD
$4.38B
| $10.8M | 0.08% |
260,703
-734,911
| -74% | -$31.7M |
|
168
Uber
UBER
$147B
| $10.7M | 0.08% |
293,445
-1,949,926
| -87% | -$64.4M |
|
|
COUP
169
DELISTED
Coupa Software Incorporated
COUP
| $10.6M | 0.08% |
+38,506
| New | +$11.2M |
|
170
Liberty Media Series C
FWONK
$25.6B
| $10.5M | 0.08% |
+299,843
| New | +$10.5M |
|
171
eBay
EBAY
$49.8B
| $10.3M | 0.08% |
197,836
-171,430
| -46% | -$9.44M |
|
172
Arcutis Biotherapeutics
ARQT
$3.56B
| $10.3M | 0.08% |
350,000
-100,000
| -22% | -$2.67M |
|
173
MaxLinear
MXL
$6.43B
| $9.67M | 0.07% |
+416,095
| New | +$10.3M |
|
|
DCPH
174
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.98M | 0.07% |
175,000
+25,000
| +17% | +$1.22M |
|
175
Zentalis Pharmaceuticals
ZNTL
$364M
| $8.83M | 0.07% |
+270,000
| New | +$9.45M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2020 Portfolio in Review
As of Q3 2020, Polar Capital held 339 positions worth $13.5B, up 16% from $11.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Polar Capital deployed $530M of net new capital in Q3 2020, opening 59 new positions and adding to 111 existing holdings. Its largest new stake was Chegg: 1,189,909 shares worth $85M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $133M trimmed.
- Polar Capital's largest Q3 2020 buy was Chegg: 1,189,909 shares worth $85M.
- Polar Capital added most to Meta Platforms (Facebook) in Q3 2020, an estimated $157M increase.
- Polar Capital's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $133M.
- Polar Capital fully exited Ciena in Q3 2020, selling an estimated $99.1M.
- Polar Capital's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2020.
- Polar Capital opened 59 new positions and closed 41 in Q3 2020.
- Polar Capital's portfolio value rose 16% quarter-over-quarter to $13.5B.
Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.